Tag Medpace

Medpace Medical Device (MMD) Announces the Addition of Diane Sahr, RN as Vice President, Clinical Affairs

Feb28

CINCINNATI, OH (MARKET WIRE) 03/01/11 Medpace, Inc. announced the addition of Diane Sahr, RN as a Vice President, Clinical Affairs for Medpace Medical Device, a wholly owned subsidiary of Medpace based in Minneapolis, MN. Medpace Medical Device conducts global clinical trials for both pre-market approval and post-market outcomes for medical device sponsors worldwide.Diane Sahr has […]

Medpace acquires Symbios clinical

Apr7

Apr 08, 2010 (Datamonitor via COMTEX) Medpace, a clinical research organization or CRO, has acquired Symbios Clinical, a CRO engaged in providing medical device clinical trials.This acquisition reportedly allows the integration of Medpace’s therapeutic expertise and global reach with the device expertise of Symbios to offer best-in-class clinical trial management solutions to medical device companies.Medpace […]

Medpace, Inc. Acquires Symbios Clinical, a US-Based Clinical Research Organization (CRO) Specializing in Medical Device Trials

Apr5

CINCINNATI, OH (MARKET WIRE) 04/06/10 Medpace, a privately held, global, full-service clinical research organization (CRO) announced that it has acquired Symbios Clinical, a CRO dedicated to medical device clinical trials with expertise in pre-market, post-approval and post-market / outcomes trials. Symbios supports the full spectrum of medical device trials.This acquisition allows the integration of Medpace’s […]

Medpace Announces the Addition of Samer E. Kaba, MD, Medical Director, Strengthening Therapeutic Expertise in Neuroscience Drug Development Services

Feb9

CINCINNATI, OH (MARKET WIRE) 02/10/10 Medpace, Inc. today announced the additionof Samer E. Kaba, MD, as a Medical Director with therapeutic expertise inguiding global clinical trials in the area of Neuroscience. Dr. Kababrings a wealth of clinical development expertise in the areas ofneurology, psychiatry, and analgesia. As a Medpace Medical Director, Dr.Kaba will be engaged […]

Medpace Medical Director, Jim Wei, MD, PhD to Present at the Outsourcing Clinical Trials Conference, January 27-28, 2010

Jan24

CINCINNATI, OH (MARKET WIRE) 01/25/10 Medpace, Inc., a leading global full-serviceclinical research organization (CRO), today announced that Dr. Jim Wei,Medpace Director, Clinical Pharmacology, will deliver a keynotepresentation, Thursday, January 28, 2010, at the Outsourcing ClinicalTrials Conference West Coast in San Francisco, January 27-28. Dr. Wei’stopic, "Conducting Strategic Clinical Trials in China: 2010," will includeinformation dealing […]

Medpace, Inc. Continues Their European Expansion With the Acquisition of Medical Consulting Dr. Schlichtiger GmbH, a European CRO With Key Expertise in Drug Development and Special Focus on Regulatory Consulting and Drug Safety

Jan17

CINCINNATI, OH (MARKET WIRE) 01/18/10 Medpace, a privately held, global,full-service clinical research organization, is pleased to announce that ithas acquired Medical Consulting Dr. Schlichtiger GmbH, a European CRO withextensive drug development expertise providing customized regulatory andpharmacovigilance services to pharmaceutical, biotechnology and nutritionalcompanies of all sizes based in Munich, Germany.Medical Consulting will add strategic expertise to […]

Medpace Sets Groundbreaking for Global Headquarters in Madisonville

Jan13

CINCINNATI, OH (MARKET WIRE) 01/14/10 Groundbreaking January 14, 2010 10:00 a.m. Madison Road & Red Bank Expressway, southeast cornerMedpace, Inc., a global leader in clinicalresearch for the pharmaceutical and biotechnology industries, hasannounced it is beginning construction on its new corporate headquarters inthe City of Cincinnati’s Madisonville neighborhood.City of Cincinnati Mayor Mark Mallory and City Manager […]

Medpace Therapeutic Expert, Charles Schmidt, MD, PhD to Present at the Pediatric Drug Development and Clinical Trials in Brussels, November 17-18, 2009

Nov9

CINCINNATI, OH (MARKET WIRE) 11/10/09 Medpace, Inc., a leading global full-serviceclinical research organization today announced that Charles Schmidt, MD,PhD, General Manager, Latin America, will speak at the Pediatric DrugDevelopment and Clinical Trials Congress in Brussels, November 2009.Topics for Dr. Schmidt’s talk on conducting pediatric clinical trials inLatin America will include: outlining the regional expertise and […]

Amarin Appoints Medpace as CRO for Two Phase 3 Cardiovascular Trials

Nov7

2009 NOV 8 – (NewsRx.com) Amarin Corporation plc (NASDAQ:AMRN) announced that it has executed an agreement with Medpace, Inc. (‘Medpace’), a leading Contract Research Organization (CRO) with expertise in conducting clinical trials in cardiovascular and metabolic disease, to engage their services in the execution of its Phase 3 clinical trials with AMR101 in patients with […]

Medpace Inc. Expands Therapeutic Capabilities With the Acquisition of Pharma Brains AG, a European CRO With Global Experience in Oncology Drug Development

Nov1

CINCINNATI, OH (MARKET WIRE) 11/02/09 Medpace, a privately held, globalfull-service clinical research organization, today announced it hasentered into a purchase agreement to acquire Pharma Brains AG, an oncologyfocused CRO based in Basel, Switzerland.Pharma Brains is an excellent fit with Medpace in terms of itscomplementary therapeutic expertise, strong leadership and qualified staff.Pharma Brains is led by […]